Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06290063 · ClinicalTrials.gov registry record · Phase 2
Cannabidiol and Older Adult Cannabis Users
A Phase 2 study of Depression and Pain, sponsored by University of Colorado, Boulder.
- Recruiting
- Registry status
- Phase 2
- Development phase
- 385
- Enrollment target
- 1
- Study location
NCT06290063 is a Phase 2 study of Depression and Pain that is actively recruiting participants, run by University of Colorado, Boulder. The registered enrollment target is 385 participants, below the 786-participant average among 679 other Depression trials with a reported enrollment target (51% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06290063, a Phase 2 study of Depression and Pain, is actively recruiting participants, sponsored by University of Colorado, Boulder.
- RECRUITING
- Registry status
- Phase 2
- Development phase
- 385 participants
- Enrollment target
- 1
- Study location
Study Summary
Cannabis use increased 10 fold among adults over the age of 65 between 2014 and 2016 but very little data exists on the extent of their harmful effects on health and behavior. The overarching goal of this project is to test a novel harm reduction strategy in which older individuals who seek to use cannabis for pain, anxiety or mood problems (depression/anxiety) will be randomly assigned to one of three conditions in an 8 week randomized controlled trial: hemp-derived CBD+THC, hemp-derived CBD-THC, or placebo. This work has the ability to directly inform individual choices regarding the use of cannabis products among older adults, and direct policy decisions regulating cannabis formulations on the legal market.
Conditions Studied
Interventions
- DRUG Placebo
- DRUG fsCBD Cannabidiol
- DRUG bsCBD Cannabidiol
Study Locations (1)
Colorado
- University of Colorado at Boulder - Boulder
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 385 participants |
| Start Date | 2024-05-01 |
| Est. Completion | 2028-08-31 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06290063
The ClinicalTrials.gov registry entry for NCT06290063 describes a study currently listed as recruiting, categorized as Phase 2. The registered enrollment target is 385 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 786-participant average among 679 other Depression trials with a reported enrollment target (51% lower). The listed sponsor is University of Colorado, Boulder, which has 69 total studies on file at ClinicalTrials.gov.
The record links to 4 conditions, with Depression appearing as the primary indexed condition, and to 3 interventions - of which Placebo is the first listed.
NCT06290063 reports 1 study location spanning 1 distinct geographic area - top geographies include Colorado.
Frequently Asked Questions
What is clinical trial NCT06290063 about?
NCT06290063 is a clinical study titled "Cannabidiol and Older Adult Cannabis Users". Cannabis use increased 10 fold among adults over the age of 65 between 2014 and 2016 but very little data exists on the extent of their harmful effects on health and behavior. The overarching goal of this project is to test a novel harm reduction strategy in which older individuals who seek to use c...
What is the current status of trial NCT06290063?
This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 385 participants. The study started on 2024-05-01. Estimated completion is 2028-08-31.
What conditions does trial NCT06290063 study?
This clinical trial studies the following conditions: Depression, Pain, Anxiety, Sleep.
What interventions are being tested in trial NCT06290063?
The interventions under investigation include: Placebo (DRUG), fsCBD Cannabidiol (DRUG), bsCBD Cannabidiol (DRUG).
Who is sponsoring clinical trial NCT06290063?
This trial is sponsored by University of Colorado, Boulder, which has 69 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06290063 being conducted?
This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Depression
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Sleep to Reduce Incident Depression Effectively in Peripartum
RECRUITING · Phase 2
-
Resources, Inspiration, Support and Empowerment (RISE) for Black Pregnant Women
RECRUITING · Phase 2
-
TRIPS - Treatment to Improve Depression and/or Anxiety Using Psilocybin-assisted Psychotherapy in Cancer Survivors
RECRUITING · Phase 2
-
Evaluation of a Keto-Like Supplement on Brain Responses to Emotional Stimuli in Depression
RECRUITING · Phase 2
-
Neurobiology of Suicide
RECRUITING · Phase 2
-
Investigation to Understand and Optimize Psilocybin
RECRUITING · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.